CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3

Journal of Immunology

Volumn 162, Issue 8, 1999, Pages 4903-4909

  Struyf, Sofie ^a   Proost, Paul ^a   Schols, Dominique ^a   De Clercq, Erik ^a   Opdenakker, Ghislain ^a   Lenaerts, Jean Pierre ^a   Detheux, Michel ^b   Parmentier, Marc ^b   De Meester, Ingrid ^c   Scharpé, Simon ^c   Van Damme, Jo ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CHEMOKINE; CHEMOKINE RECEPTOR; EOTAXIN; PROLINE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CELL ISOLATION; CHEMOTAXIS; DRUG ACTIVITY; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME REGULATION; EOSINOPHIL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 0033561659     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Luster, A. D. 1998. Chemokines, chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436.
2. Rollins, B. J. 1997. Chemokines. Blood 90:909.
3. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15:675.
4. Yoshie, O., T. Imai, and H. Nomiyama. 1997. Novel lymphocyte-specific CC chemokines and their receptors. J. Leukocyte Biol. 62:634.
5. Doms, R. W., and S. C. Peiper. 1997. Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry. Virology 235:179.
6. Broder, C. C., and R. G. Collman. 1997. Chemokine receptors and HIV. J. Leukocyte Biol. 62:20.
7. D'Souza, M. P., and V. A. Harden. 1996. Chemokines and HIV-1 second receptors: confluence of two fields generates optimism in AIDS research. Nat. Med. 2:1293.
8. Connor, R. I., K. E. Sheridan, D. Ceradini, S. Choe, and N. R. Landau. 1997. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185:621.
9. Scarlatti, G., E. Tresoldi, A. Bjömdal, R. Fredriksson, C. Colognesi, H. K. Deng, M. S. Malnati, A. Plebani, A. G. Siccardi, D. R. Littman, et al. 1997. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat. Med. 3:1259.
10. Choc, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, et al. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135.
11. Alkhatib, G., E. A. Berger, P. M. Murphy, and J. E. Pease. 1997. Determinants of HIV-1 coreceptor function on CC chemokine receptor 3: importance of both extracellular and transmembrane/cytoplasmic regions. J. Biol. Chem. 272:20420.
12. He, J., Y. Chen, M. Farzan, H. Choe, A. Ohagen, S. Gartner, J. Busciglio, X. Yang, W. Hofmann, W. Newman, et al. 1997. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385:645.
13. McKnight, A., M. T. Dittmar, J. Moniz-Periera, K. Ariyoshi, J. D. Reeves, S. Hibbitts, D. Whitby, E. Aarons, A. E. Proudfoot, H. Whittle, et al. 1998. A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4. J. Virol. 72:4065.
14. Garcia-Zepeda, E. A., M. E. Rothenberg, R. T. Ownbey, J. Celestin, P. Leder, and A. D. Luster. 1996. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat. Med. 2:449.
15. Ponath, P. D., S. Qin, D. J. Ringler, I. Clark-Lewis, J. Wang, N. Kassam, H. Smith, X. Shi, J.-A. Gonzalo, W. Newman, et al. 1996. Cloning of the human eosinophil chemoattractant, eotaxin: expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97:604.
16. Luster, A. D., and M. E. Rothenberg. 1997. Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation. J. Leukocyte Biol. 62:620.
17. Forssmann, U., M. Uguccioni, P. Loetscher, C. A. Dahinden, H. Langen, M. Thelen, and M. Baggiolini. 1997. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J. Exp. Med. 185:2171.
18. White, J. R., C. Imburgia, E. Dul, E. Appelbaum, K. O'Donnell, D. J. O'Shannessy, M. Brawner, J. Fornwald, J. Adamou, N. A. Elshourbagy, et al. 1997. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J. Leukocyte Biol. 62:667.
19. Patel, V. P., B. L. Kreider, Y. Li, H. Li, K. Leung, T. Salcedo, B. Nardelli, V. Pippalla, S. Gentz, R. Thotakura, et al. 1997. Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors. J. Exp. Med. 185:1163.
20. Yamada, H., K. Hirai, M. Miyamasu, M. Iikura, Y. Misaki, S. Shoji, T. Takaishi, T. Kasahara, Y. Monta, and K. Ito. 1997. Eotaxin is a potent chemotaxin for human basophils. Biochem. Biophys. Res. Commun. 231:365.
21. Uguccioni, M., C. R. Mackay, B. Ochensberger, P. Loetscher, S. Rhis, G. J. LaRosa, P. Rao, P. D. Ponath, M. Baggiolini, and C. A. Dahinden. 1997. High expression of the chemokine receptor CCR3 in human blood basophils: role in activation by eotaxin, MCP-4, and other chemokines. J. Clin. Invest. 100:1137.
22. Gerber, B. O., M. P. Zanni, M. Uguccioni, M. Loetscher, C. R. Mackay, W. J. Pichler, N. Yawalkar, M. Baggiolini, and B. Moser. 1997. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr. Biol. 7:836.
23. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005.
24. Bonecchi, R., G. Bianchi, P. P. Bordignon, D. D'Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. W. Gray, A. Mantovani, et al. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:129.
25. Proost, P., I. De Meester, D. Schols, S. Struyf, A.-M. Lambeir, A. Wuyts, G. Opdenakker, E. De Clercq, S. Scharpé, and J. Van Damme. 1998. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV: conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J. Biol. Chem. 273:7222.
26. Oravecz, T., M. Pall, G. Roderiquez, M. D. Gorrell, M. Ditto, N. Y. Nguyen, R. Boykins, E. Unsworth, and M. A. Norcross. 1997. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-medi-ated cleavage. J. Exp. Med. 186:1865.
27. Vanhoof, G., F. Goossens, I. De Meester, D. Hendriks, and S. Scharpé. 1995. Praline motifs in peptides and their biological processing. FASEB J. 9:736.
28. Morimoto, C., and S. F. Schlossman. 1998. The structure and function of CD26 in the T-cell immune response. Immunol. Rev. 161:55.
29. von Bonin, A., J. Hühn, and B. Fleischer. 1998. Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway. Immunol. Rev. 161:43.
30. Samson, M., G. LaRosa, F. Libert, P. Paindavoine, M. Detheux, G. Vassart, and M. Parmentier. 1997. The second extracellular loop of CCR5 is the major determinant of ligand specificity. J. Biol. Chem. 272:24934.
31. Deng, H., D. Unutmatz, V. N. KewalRamani, and D. R. Littman. 1997. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388:296.
32. De Meester, I., G. Vanhoof, A.-M. Lambeir, and S. Scharpé. 1996. Use of immobilized adenosine deaminase (EC 3. 5.4.4) for the rapid purification of native human CD26/dipeptidyl peptidase IV (EC 3.4.14.5). J. Immunol. Methods 189: 99.
33. Schägger, H., and G. Von Jagow. 1987. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:368.
34. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 440.
35. Larson, E., B. Howlett, and A. Jagendorf. 1986. Artificial reductant enhancement of the Lowry method for protein determination. Anal. Biochem. 155:243.
36. Rey, M. A., B. Krust, A. G. Laurent, D. Guétard, L. Montagnier, and A. G. Hovanessian. 1989. Characterization of an HIV-2-related virus with a smaller sized extracellular envelope glycoprotein. Virology 173:258.
37. Brön, R., P. J. Klasse, D. Wilkinson, P. R. Clapham, A. Pelchen-Matthews, C. Power, T. N. Wells, J. Kim, S. C. Peiper, J. A. Hoxie, et al. Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein. 1997. J. Virol. 71:8405.
38. Proost, P., S. Struyf, D. Schols, C. Durinx, A. Wuyts, J.-P. Lenaerts, E. De Clercq, I. De Meester, and J. Van Damme. 1998. Processing by CD26/ dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1α. FEBS Lett. 432:73.
39. Ohtsuki, T., O. Hosono, H. Kobayashi, Y. Munakata, A. Souta, T. Shioda, and C. Morimoto. 1998. Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1α by CD26/ dipeptidyl peptidase IV. FEBS Lett. 431:236.
40. Jose, P. J., D. A. Griffiths-Johnson, P. D. Collins, D. T. Walsh, R. Moqbel, N. F. Totty, O. Truong, J. J. Hsuan, and T. J. Williams. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179:881.
41. Humbles, A. A., D. M. Conroy, S. Marleau, S. M. Rankin, R. T. Palframan, A. E. Proudfoot, T. N. Wells, D. Li, P. K. Jeffery, D. A. Griffiths-Johnson, et al. 1997. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J. Exp. Med. 186:601.
42. Lamkhioued, B., P. M. Renzi, S. Abi-Younes, E. A. Garcia-Zepeda, Z. Allakhverdi, O. Ghaffar, M. D. Rothenberg, A. D. Luster, and Q. Hamid. 1997. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J. Immunol. 159:4593.
43. MacLean, J. A., R. Ownbey, and A. D. Luster. 1996. T cell-dependent regulation of eotaxin in antigen-induced pulmonary eosinophila. J. Exp. Med. 184:1461.
44. Mattoli, S., M. A. Stacey, G. Sun, A. Bellini, and M. Marini. 1997. Eotaxin expression and eosinophilic inflammation in asthma. Biochem. Biophys. Res. Commun. 236:299.
45. Rothenberg, M. E., A. D. Luster, C. M. Lilly, J. M. Drazen, and P. Leder. 1995. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J. Exp. Med. 181:1211.
46. Ying, S., D. S. Robinson, Q. Meng, J. Rottman, R. Kennedy, D. J. Ringler, C. R. Mackay, B. L. Daugherty, M. S. Springer, S. R. Durham, et al. 1997. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma: association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur. J. Immunol. 27:3507.
47. Teixeira, M. M., T. N. Wells, N. W. Lukacs, A. E. Proudfoot, S. L. Kunkel, T. J. Williams, and P. G. Hellewell. 1997. Chemokine-induced eosinophil recruitment: evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J. Clin. Invest. 100:1657.
48. Rothenberg, M. E., J. A. MacLean, E. Pearlman, A. D. Luster, and P. Leder. 1997. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med. 185:785.
49. Matthews, A. N., D. S. Friend, N. Zimmermann, M. N. Sarafi, A. D. Luster, E. Pearlman, S. E. Wen, and M. E. Rothenberg. 1998. Eotaxin is required for the baseline level of tissue eosinophils. Proc. Natl. Acad. Sci. USA 95:6273.
50. Elsner, J., R. Höchstetter, D. Kimmig, and A. Kapp. 1996. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils. Eur. J. Immunol. 26:1919.
51. 2+-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive helerotrimeric guanine nucleotide-binding protein. Blood 88:3195.
52. Palframan, R. T., P. D. Collins, T. J. Williams, and S. M. Rankin. 1998. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 91:2240.
53. Collins, P. D., S. Marleau, D. A. Griffiths-Johnson, P. J. Jose, and T. J. Williams. 1995. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182:1169.
54. Mould, A. W., K. I. Matthaei, I. G. Young, and P. S. Foster. 1997. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J. Clin. Invest. 99:1064.
55. Peled, A., J. A. Gonzalo, C. Lloyd, and J.-C. Gutierrez-Ramos. 1998. The chemotactic cytokine eotaxin acts as a granulocyte-macrophage colony-stimulating factor during lung inflammation. Blood 91:1909.
56. Noso, N., J. Bartels, A. I. Mallet, M. Mochizuki, E. Christophers, and J.-M. Schröder. 1998. Delayed production of biologically active O-glycosylated forms of human eotaxin by tumor-necrosis-factor-α-stimulated dermal fibroblasts. Eur. J. Biochem. 253:114.
57. Mochizuki, M., J. Bartels, A. I. Mallet, E. Christophers, and J.-M. Schröder. 1998. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J. Immunol. 160:60.
58. Struyf, S., I. De Meester, S. Scharpé, J.-P. Lenaerts, P. Menten, J. M. Wang, P. Proost, and J. Van Damme. 1998. Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor. Eur. J. Immunol. 28:1262.
59. Van Coillie, E., P. Proost, I. Van Aelst, S. Struyf, M. Polfliet, I. De Meester, D. Harvey, J. Van Damme, and G. Opdenakker. 1998. Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV. Biochemistry 37:12672.
60. Saison, M., J. Verlinden, F. Van Leuven, J.-J. Cassiman, and H. Van Den Berghe. 1983. Identification of cell surface dipeptidyl-peptidase IV in human fibroblasts. Biochem. J. 216:177.
61. Lilly, C. M., H. Nakamura, H. Kesselman, C. Nagler-Anderson, K. Asano, E. A. Garcia-Zepeda, M. E. Rothenberg, J. M. Drazen, and A. D. Luster. 1997. Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J. Clin. Invest. 99:1767.
62. Vanhoof, G., I. De Meester, M. van Sande, S. Scharpé, and A. Yaron. 1992. Distribution of proline-specific aminopeptidases in human tissues and body fluids. Eur. J. Clin. Chem. Clin. Biochem. 30:333.
63. Van der Velden, V. H., A. F. Wierenga-Wolf, P. W. Adriaansen-Soeting, S. E. Overbeek, G. M. Möller, H. C. Hoogsteden, and M. A. Versnel. 1998. Expression of aminopeptidase N and dipeptidyl peptidase IV in the healthy and asthmatic bronchus. Clin. Exp. Allergy 28:110.
64. Humbert, M., S. Ying, C. Corrigan, G. Menz, J. Barkans, R. Pfister, Q. Meng, J. Van Damme, G. Opdenakker, S. R. Durham, et al. 1997. Bronchial mucosa expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-S, granulocyte macrophage-colony-stimulating factor, and IL-3. Am. J. Respir. Cell. Mol Biol. 16:1.
65. Stellato, C., P. Collins, P. D. Ponath, D. Soler, W. Newman, G. LaRosa, H. Li, J. White, L. M. Schwiebert, C. Bickel, et al. 1997. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J. Clin. Invest. 99:926.
66. Hogaboam, C., S. L. Kunkel, R. M. Strieter, D. D. Taub, P. Lincoln, T. J. Standiford, and N. W. Lukacs. 1998. Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cell-fibroblast interactions. J. Immunol. 160:6166.